Short Interest in Apollomics, Inc. (NASDAQ:APLMW) Rises By 342.9%

Apollomics, Inc. (NASDAQ:APLMW) was the target of a large growth in short interest during the month of August. As of August 31st, there was short interest totalling 18,600 shares, a growth of 342.9% from the August 15th total of 4,200 shares. Based on an average daily volume of 14,100 shares, the short-interest ratio is currently 1.3 days.

Apollomics Price Performance

APLMW remained flat at $0.01 during mid-day trading on Thursday. 14,037 shares of the company’s stock were exchanged, compared to its average volume of 26,651. Apollomics has a 1 year low of $0.01 and a 1 year high of $0.10. The business has a 50-day moving average of $0.01 and a 200 day moving average of $0.02.

About Apollomics

Apollomics, Inc, a biotechnology company, engages in the discovery and development of mono and combination oncology therapies to harness the immune system and target specific molecular pathways to inhibit cancer. Its pipeline consists of various development-stage assets, including novel and humanized monoclonal antibodies that restore the body's immune system to recognize and kill cancer cells, and targeted therapies against uncontrolled growth signaling pathways.